OWC Pharmaceutical Research Corp (OWCP)

[Babubd]

OWCP $$$ Coming. Folks, believe it or not! $OWCP is gonna be BIG, very very BIG beyond your imagination. Over $200 Billion US marijuana industry is around the corner.

https://secure.outsiderclub.com/137658?device=m&gclid=Cj0KCQiAy579BRCPARIsAB6QoIZmlK4yQHeSkBo6FeknjSTFjaEM63BC7AKPQnFM62Xp8EpE_Tdo5IUaAmE8EALw_wcB

OWCP ran from $0.003 to $0.154 per share in Dec., 2019. We may see similar type of run anytime now.

3-Yr high was over $0.66 per share and 5-Yr high was over $3 per share!! Just beautiful.

Number of share outstanding is only 497.49 million with a float of 206.51 million. With such a low share structure anything is possible.

https://www.otcmarkets.com/stock/OWCP/security

Go $OWCP go and break all time high!! $OWCP

KNOW WHAT YOU OWN

OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

Intellectual Property

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings and Continuations in Part (CIP). The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.

RICHTER & SHIMONI
OWC's main Patent Agency located in Israel, Germany and Switzerland
Richter engages patent lawyers in other domains for filing purposes
Dr. Gila Shimoni is primary author/editor of patent application content

BROWDY & NEIMARK'S WEBSITE (USPTO)
Browdy is OWC's U.S. Intellectual Property Law Firm

DENNEMEYER & CO. WEBSITE (AUSPAT)
Chronic Pain - Emulsions

https://investorshub.advfn.com/OWC-Pharmaceutical-Research-Corp-OWCP-16859/

https://www.owcpharma.com/pain-managment-research/